Gabriela A.: New FDA Approval Advances the Future of Dried Plasma
Gabriela A., Project Coordinator at UT Health San Antonio, shared a post on LinkedIn:
”The FDA’s recent approval of ‘Ezplaz’, the first-ever-dried plasma product licensed in the United States, marks a major advancement in trauma care, particularly for military, emergency response, and other austere environments where traditional blood products are difficult to store and transport.
This milestone highlights the growing momentum behind blood preservation research, including TRC4-supported work at UTAustin, where investigators are exploring innovative thin-film freeze-drying approaches that could help shape the future of blood product storage, transport, and use in austere environments.
It’s exciting to see innovations once considered aspirational become reality, while groundbreaking research across The University of Texas System continues to transform bold ideas into real-world solutions.”
Stay uodated with Hemostasis Today.
-
Oct 2, 2026, 06:00Susan Wickersham: Gradual Shift towards Autologous Blood Transfusion is a Current Trend
-
Oct 2, 2026, 05:54Shamee Shastry: When Every Cell Reacts – The Hunt for Rare Blood
-
Oct 2, 2026, 05:49David Mclntosh: Expanding Plasma Protein Therapies in Underserved Regions
-
Oct 2, 2026, 05:38Dianne E. van der Wal: C-Terminal Endings Impact PAR1/PAR4 Peptide Potency in In Vitro Platelet Assays
-
Oct 2, 2026, 05:29Mohammed Alo: Your LDL Isn’t a Snapshot – It’s a Smoking Habit Measured in Years
-
Oct 2, 2026, 00:33Marwa Mostafa: Hemoglobinopathies – When Globin Genes Go Wrong
-
Oct 1, 2026, 23:46Behnood Bikdeli: Global Burden of Venous Thromboembolism
-
Oct 1, 2026, 23:46Sthanu Subramanian: Clinical Presentation, Risk Factors, Diagnosis, and Neuroimaging Findings in CVT
-
Oct 1, 2026, 23:45Martha Gulati: Oral MHT Is Associated With Increased Thrombotic Risk